Real-life comparison of the afatinib and first-generation tyrosine kinase inhibitors in nonsmall cell lung cancer harboring EGFR exon 19 deletion: a Turk Oncology Group (TOG) study. - Bilgin, Burak; Sendur, Mehmet Ali Nahit; Yucel, Sebnem; Celik, Emir; Ozyukseler, Deniz Tataroglu; Ayhan, Murat; Basoglu, Tugba; Ilhan, Aysegul; Akdeniz, Nadiye; Gulmez, Ahmet; Dogan, Izzet; Aktas, Burak Yasin; et al. (Journal of Cancer Research & Clinical Oncology, 2021)